These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 3554950)

  • 1. Clinical types of proarrhythmic response to antiarrhythmic drugs.
    Bigger JT; Sahar DI
    Am J Cardiol; 1987 Apr; 59(11):2E-9E. PubMed ID: 3554950
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proarrhythmic effects of antiarrhythmic drugs.
    Ross DL; Cooper MJ; Koo CC; Skinner MP; Davis LM; Richards DA; Uther JB
    Med J Aust; 1990 Jul; 153(1):37-47. PubMed ID: 2199804
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The pro-arrhythmia effects of anti-arrhythmia agents--theoretical and clinical aspects].
    Steinbeck G
    Z Kardiol; 1992; 81 Suppl 4():139-43. PubMed ID: 1290290
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and safety of class IC antiarrhythmic agents for the treatment of coexisting supraventricular and ventricular tachycardia.
    Rinkenberger RL; Naccarelli GV; Berns E; Dougherty AH
    Am J Cardiol; 1988 Aug; 62(6):44D-55D. PubMed ID: 3136636
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proarrhythmic responses during electrophysiologic testing.
    Horowitz LN; Greenspan AM; Rae AP; Kay HR; Spielman SR
    Am J Cardiol; 1987 Apr; 59(11):45E-48E. PubMed ID: 3578040
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proarrhythmic effects of antiarrhythmic drugs assessed by electrophysiologic study in recurrent sustained ventricular tachycardia.
    Chinushi M; Aizawa Y; Miyajima S; Funazaki T; Tamura M; Shibata A
    Jpn Circ J; 1991 Feb; 55(2):133-41. PubMed ID: 2020083
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Proarrhythmic effects of anti-arrhythmia agents].
    Scanu P; Agostini D; Grollier G; Belin A; Valette B; Potier JC
    Rev Med Interne; 1995; 16(8):602-7. PubMed ID: 7569432
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Antiarrhythmic therapy in patients with heart failure].
    Faber TS; Zehender M
    Ther Umsch; 2000 May; 57(5):324-32. PubMed ID: 10859993
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The pro-arrhythmic effects of anti-arrhythmia agents].
    Haverkamp W; Wichter T; Chen X; Hördt M; Willems S; Rotman B; Hindricks G; Kottkamp H; Borggrefe M; Breithardt G
    Z Kardiol; 1994; 83 Suppl 5():75-85. PubMed ID: 7846949
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proarrhythmic actions of antiarrhythmic drugs: a review.
    Campbell TJ
    Aust N Z J Med; 1990 Jun; 20(3):275-82. PubMed ID: 2196873
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Provocation of supraventricular tachycardias by an intravenous class I antiarrhythmic drug.
    Brembilla-Perrot B; Terrier de la Chaise A
    Int J Cardiol; 1992 Feb; 34(2):189-98. PubMed ID: 1737670
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proarrhythmia with class III antiarrhythmic drugs: types, risks, and management.
    Hohnloser SH
    Am J Cardiol; 1997 Oct; 80(8A):82G-89G. PubMed ID: 9354415
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proarrhythmia during drug treatment of supraventricular tachycardia: paradoxical risk of sinus rhythm for sudden death.
    Prystowsky EN
    Am J Cardiol; 1996 Oct; 78(8A):35-41. PubMed ID: 8903274
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proarrhythmic effects of intravenous vasopressors.
    Tisdale JE; Patel RV; Webb CR; Borzak S; Zarowitz BJ
    Ann Pharmacother; 1995 Mar; 29(3):269-81. PubMed ID: 7606074
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proarrhythmic effects of antiarrhythmic drugs during programmed ventricular stimulation in patients without ventricular tachycardia.
    Au PK; Bhandari AK; Bream R; Schreck D; Siddiqi R; Rahimtoola SH
    J Am Coll Cardiol; 1987 Feb; 9(2):389-97. PubMed ID: 2433319
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Cardiac side effects of anti-arrhythmia agents].
    Seipel L
    Z Kardiol; 1988 Feb; 77(2):77-88. PubMed ID: 3284219
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanisms and management of proarrhythmia.
    Roden DM
    Am J Cardiol; 1998 Aug; 82(4A):49I-57I. PubMed ID: 9737654
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiarrhythmic effects of a novel class III drug, KCB-328, on canine ventricular arrhythmia models.
    Xue Y; Tanabe S; Nabuchi Y; Hashimoto K
    J Cardiovasc Pharmacol; 1998 Aug; 32(2):239-47. PubMed ID: 9700986
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proarrhythmia: a paradoxic response to antiarrhythmic agents.
    McCollam PL; Parker RB; Beckman KJ; Hariman RJ; Bauman JL
    Pharmacotherapy; 1989; 9(3):144-53. PubMed ID: 2666959
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined potassium and calcium channel blocking activities as a basis for antiarrhythmic efficacy with low proarrhythmic risk: experimental profile of BRL-32872.
    Bril A; Gout B; Bonhomme M; Landais L; Faivre JF; Linee P; Poyser RH; Ruffolo RR
    J Pharmacol Exp Ther; 1996 Feb; 276(2):637-46. PubMed ID: 8632331
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.